Zobrazeno 1 - 10
of 610
pro vyhledávání: '"Waldron-Lynch F"'
Autor:
Hakim AD; Providence Little Company of Mary Medical Center, Torrance, CA, USA., Awili M; Dallas Regional Medical Center, Mesquite, TX, USA., O'Neal HR; Louisiana State University Health Sciences Center and Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, USA., Siddiqi O; Boston Medical Center, Boston, MA, USA., Jaffrani N; Rapides Regional Medical Center, Alexandria, LA, USA., Lee R; University of California, Irvine, CA, USA., Overcash JS; Sharp Grossmont Hospital, La Mesa, CA, USA., Chauffe A; Louisiana State University Health Sciences Center, Lafayette, LA, USA., Hammond TC; Saint Johns Cancer Institute, Santa Monica, CA, USA., Patel B; University of Texas McGovern Medical School, Houston, TX, US., Waters M; Sharp Chula Vista Medical Center, Chula Vista, CA, USA., Criner GJ; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA., Pachori A; MorphoSys AG, Boston, MA, USA., Junge G; Novartis Pharma AG, Basel, Switzerland., Levitch R; Novartis Pharma AG, Basel, Switzerland., Watts J; Oculis, Boston, MA, USA., Koo P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sengupta T; Novartis Healthcare Pvt Ltd, Hi-Tech City, Hyderabad, India., Yu L; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Kiffe M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Pinck A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Stein RR; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bendrick-Peart J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Jenkins J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Rowlands M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Waldron-Lynch F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Matthews J; Hospital Medicine, St Charles Health System, Bend, OR, USA.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2023 Oct 13; Vol. 213 (3), pp. 265-275.
Autor:
Dunger, David B., Bruggraber, Sylvaine F. A., Mander, Adrian P., Marcovecchio, M. Loredana, Tree, Timothy, Chmura, Piotr Jaroslaw, Knip, Mikael, Schulte, Anke M., Mathieu, Chantal, Mathieu, C., Gillard, P., Casteels, K., Overbergh, L., Dunger, D., Wallace, C., Evans, M., Thankamony, A., Hendriks, E., Bruggraber, S., Peakman, M., Tree, T., Morgan, N., Richardson, S., Todd, J., Wicker, L., Mander, A., Dayan, C., Alhadj Ali, M., Pieber, T., Eizirik, D., Cnop, M., Brunak, S., Pociot, F., Johannesen, J., Rossing, P., Legido Quigley, C., Mallone, R., Scharfmann, R., Boitard, C., Knip, M., Otonkoski, T., Veijola, R., Lahesmaa, R., Oresic, M., Toppari, J., Danne, T., Ziegler, A. G., Achenbach, P., Rodriguez-Calvo, T., Solimena, M., Bonifacio, E., Speier, S., Holl, R., Dotta, F., Chiarelli, F., Marchetti, P., Bosi, E., Cianfarani, S., Ciampalini, P., de Beaufort, C., Dahl-Jørgensen, K., Skrivarhaug, T., Joner, G., Krogvold, L., Jarosz-Chobot, P., Battelino, T., Thorens, B., Gotthardt, M., Roep, B., Nikolic, T., Zaldumbide, A., Lernmark, A., Lundgren, M., Costecalde, G., Strube, T., Schulte, A., Nitsche, A., von Herrath, M., Wesley, J., Napolitano-Rosen, A., Thomas, M., Schloot, N., Goldfine, A., Waldron-Lynch, F., Kompa, J., Vedala, A., Hartmann, N., Nicolas, G., van Rampelbergh, J., Bovy, N., Dutta, S., Soderberg, J., Ahmed, S., Martin, F., Agiostratidou, G., Koralova, A., Willemsen, R., Smith, A., Anand, B., Puthi, V., Zac-Varghese, S., Datta, V., Dias, R., Sundaram, P., Vaidya, B., Patterson, C., Owen, K., Piel, B., Heller, S., Randell, T., Gazis, T., Bismuth Reismen, E., Carel, J-C, Riveline, J-P, Gautier, J-F, Andreelli, F., Travert, F., Cosson, E., Penfornis, A., Petit, C., Feve, B., Lucidarme, N., Beressi, J-P, Ajzenman, C., Radu, A., Greteau-Hamoumou, S., Bibal, C., Meissner, T., Heidtmann, B., Toni, S., Rami-Merhar, B., Eeckhout, B., Peene, B., Vantongerloo, N., Maes, T., Gommers, L., Marcovecchio, M.L., Vela, J., Latres, E.
Publikováno v:
Dunger, D B, Bruggraber, S F A, Mander, A P, Marcovecchio, M L, Tree, T, Chmura, P J, Knip, M, Schulte, A M, Mathieu, C & INNODIA consortium 2022, ' INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes ', Trials, vol. 23, no. 1, 414 . https://doi.org/10.1186/s13063-022-06259-z
Trials 23:414 (2022)
Trials 23:414 (2022)
Background The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised collection of clinical sam
Publikováno v:
In American Journal of Transplantation October 2012 12(10):2652-2662
Autor:
Inaba A; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK., Tuong ZK; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK., Zhao TX; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Stewart AP; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK., Mathews R; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK., Truman L; Ear, Nose Throat Department, West Suffolk Hospital, Bury St Edmunds, UK., Sriranjan R; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK., Kennet J; Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Cambridge, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge, Cambridge, UK.; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK., Wicker L; Medical Sciences Division, University of Oxford, Oxford, UK., Waldron-Lynch F; Novartis Institutes for BioMedical Research, Autoimmunity Transplantation Inflammation, Basel, Switzerland., Cheriyan J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK., Todd JA; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Mallat Z; Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK.; Universite de Paris and INSERM, Paris, France., Clatworthy MR; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK. mrc38@cam.ac.uk.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK. mrc38@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 12; Vol. 14 (1), pp. 2071. Date of Electronic Publication: 2023 Apr 12.
Autor:
Zhang JY; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Hamey F; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Trzupek D; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Mickunas M; Department of Immunobiology, King's College London, School of Immunology and Microbial Sciences, London, UK., Lee M; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Godfrey L; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Yang JHM; Department of Immunobiology, King's College London, School of Immunology and Microbial Sciences, London, UK., Pekalski ML; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Kennet J; Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.; National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Biomedical Campus, Cambridge, UK., Waldron-Lynch F; Vertex Pharmaceuticals, Vertex Cell & Gene Therapies, Boston, MA, USA., Evans ML; Wellcome-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.; National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Biomedical Campus, Cambridge, UK., Tree TIM; Department of Immunobiology, King's College London, School of Immunology and Microbial Sciences, London, UK., Wicker LS; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Todd JA; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. john.todd@well.ox.ac.uk., Ferreira RC; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. ricardo.ferreira@well.ox.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Nov 28; Vol. 13 (1), pp. 7324. Date of Electronic Publication: 2022 Nov 28.
Autor:
Ferreira, RC, Rainbow, DB, Rubio García, A, Pekalski, ML, Porter, L, Oliveira, JJ, Waldron-Lynch, F, Wicker, LS, Todd, JA
Publikováno v:
Clinical Immunology (Orlando, Fla.)
To date many clinical studies aim to increase the number and/or fitness of CD4+ CD127lowCD25+ regulatory T cells (Tregs) in vivo to harness their regulatory potential in the context of treating autoimmune disease. Here, we sought to define the phenot
Autor:
Waldron-Lynch, F, Adams, C, Amos, C, Zhu, D K, McDermott, M F, Shanahan, F, Molloy, M G, O’Gara, F
Publikováno v:
Genes & Immunity. Apr2001, Vol. 2 Issue 2, p82. 6p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2
Autor:
Waldron-Lynch, F
The maintenance of peripheral naïve T lymphocytes in humans is dependent on their homeostatic division, not continuing emigration from the thymus, which undergoes involution with age. However, post-thymic maintenance of naïve T cells is still poorl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a638b8fb1f79cdd376d703eae074e3d
https://www.repository.cam.ac.uk/handle/1810/267345
https://www.repository.cam.ac.uk/handle/1810/267345
Autor:
Ferreira, R, Rainbow, D, Rubio García, A, Pekalski, M, Porter, L, Oliveira, J, Waldron-Lynch, F, Wicker, L, Todd, J
Publikováno v:
Data in Brief, Vol 12, Iss C, Pp 676-691 (2017)
We provide in this paper a detailed characterization of the human peripheral CD4$^+$ CD127$^{low}$CD25$^+$ regulatory T cell (Treg) compartment, with a particular emphasis in defining the population expressing higher levels of the IL-6 receptor (IL-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0b78ad3a8be4a869c75736f4fd4814d9
https://www.repository.cam.ac.uk/handle/1810/265140
https://www.repository.cam.ac.uk/handle/1810/265140